Assistant Professor, Oncology, Mayo Medical School

Oncology

Prashant Kapoor works in the field of Oncology. He went to Seth G.S. Medical College. Doctor Prashant Kapoor, MD is a published doctor as well. He has 26 publications published. The latest was: The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma. Prashant Kapoor accepts Medicare.

Publications

---

• Consolidation and Maintenance Therapies for Newly Diagnosed Multiple Myeloma in the Era of Novel Agents.
• Outcomes of primary refractory multiple Myeloma and the impact of novel therapies.
• Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple Myeloma.
• Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis.
• Soluble suppression of tumorigenicity 2 (sST2), but not Galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and Tropo...
• Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma Cell dyscrasias.
• Quantification of clonal circulating plasma Cells in relapsed multiple myeloma.
• Mantle cell Lymphoma: a great masquerader.
• Long-term outcome of patients with multiple Myeloma-related advanced renal failure following auto-SCT.
• Trends in survival of patients with primary plasma cell Leukemia: a population based analysis.
• Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem Cell transplant.
• Quantification of clonal circulating plasma Cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma.
• Long-term Disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy.
• Continued improvement in survival in multiple Myeloma: changes in early mortality and outcomes in older patients.
• Smoldering multiple Myeloma requiring treatment: time for a new definition?
• Implications of continued response after autologous stem Cell transplantation for multiple myeloma.
• Outcomes of patients with POEMS Syndrome treated initially with radiation.
• Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple Myeloma.
• Management of newly diagnosed symptomatic multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.
• Systemic amyloidosis associated with chronic lymphocytic Leukemia/small lymphocytic lymphoma.
• Impact of risk stratification on outcome among patients with multiple Myeloma receiving initial therapy with lenalidomide and dexamethasone.
• Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple Myeloma: identification of patients needing therapy.
• Improvement in renal function and its impact on survival in patients with newly diagnosed multiple Myeloma.
• The prognostic significance of CD45 expression by clonal bone marrow plasma Cells in patients with newly diagnosed multiple myeloma.
• Occurrence and prognostic significance of cytogenetic evolution in patients with multiple Myeloma.

Procedures Preformed

---

• HPC Transplantation (Stem Cell Transplant)
• Thoracentesis

Conditions Treated

---

• Acute Leukemia
• Anal and Rectal Cancer
• Anemia
• Antiphospholipid Syndrome (APS)
• View All

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology

Accepted Insurances

---

• Assurant Health
• Blue Card PPO
• Blue Cross Blue Shield of Illinois PPO
• Blue Cross Accord
• Commercial Insurance Company
• Choice Care PPO
• Medica
• Medicare MCR
• Meritain Health
• MultiPlan PPO
• PHCS Network PPO
• Priority Health
• Choice Plus POS
• Options PPO
• United Healthcare

Education

---

• Mayo School of Graduate Medical Education
• Seth G.S. Medical College

Hospital

---

• Mayo Clinic - Rochester, Minnesota

Drug Facts

---

NPI NUMBER		1487671152
NPPES Provider LastName		KAPOOR
NPPES Provider FirstName		PRASHANT
NPPES Provider ZIPCode		559050001
NPPES Provider State		MN
Specialty Description		Hematology/Oncology
Total Claim Count		197.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1487671152
Last Name Of The Provider	KAPOOR
First Name Of The Provider	PRASHANT
View All

Similar Doctors

---

	Dr. Jan C. Buckner, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Ayalew Tefferi, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Charles L. Loprinzi, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Animesh D. Pardanani, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Aminah Jatoi, MD This Doctor is OpenDoctor Recommended.
	Dr. Paul Haluska Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Sani H. Kizilbash, MD This Doctor is OpenDoctor Recommended.
	Dr. Joleen M. Hubbard, MD This Doctor is OpenDoctor Recommended.
	Dr. Shaji K. Kumar, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. David T. Owens, MD This Doctor is OpenDoctor Recommended.
	Dr. Michaela S. Banck, MD This Doctor is OpenDoctor Recommended.
	Dr. Ronald L. Richardson, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog